Skip to main content
. 2021 Jun 22;14:53. doi: 10.1186/s40545-021-00330-x

Fig. 5.

Fig. 5

Information need about biologicals in general and biosimilars in specific among community pharmacists. EMA European Medicines Agency, FAMHP Federal Agency for Medicines and Health Products (Belgian National Competent Authority), KOL key opinion leader, LMWH low molecular weight heparins, N number, NIHDI National Institute for Health and Disability Insurance (Belgian national health insurer), TNF-alfa blockers tumor necrosis factor-alfa blockers